Professor Meta Roestenberg from Leiden University Medical Center has won the Mercator Sapiens Stimulus prize, worth one million euros, for her work on developing a new malaria vaccine.

The project is focused on improving gene editing and gene therapy manufacturing, strengthening Europe’s position in these areas.

The Stichting LBSP (Leiden Bio Science Park Foundation) is proud to announce the partnership with 360Pharma, supported by the Career Lab initiative, to launch an advanced talent portal on the 16th March 2025.

Leiden, Netherlands – January 28, 2025 – MIMETAS, a leader in human disease modeling, has launched OrganoPlate UniFlow (UF), the first commercially available unidirectional, gravity-driven pumpless flow system for drug discovery and disease research. The platform debuts at SLAS 2025, expanding MIMETAS’ portfolio of advanced tissue models.

Leiden, 22 January 2025 – Toxys has been awarded £1 million in funding for phase 2 of the CrossDART CRACK IT Challenge, following the successful completion of phase 1. This initiative focuses on developing reliable cell-based in vitro assays that can predict the teratogenicity of new drug candidates across multiple species, reducing the need for animal testing in reproductive toxicology studies.

Leiden Bio Science Park Director Esther Peters joined Gerry van Bakel on Sleutelstad ‘s Kennismakers to discuss the park's role in shaping The...

Pharming Group has nominated Fabrice Chouraqui as the successor to CEO Sijmen de Vries. His appointment will be subject to approval at an...

Toxys and Unilever have joined forces to advance New Approach Methodologies (NAMs) for assessing cellular stress—an essential factor in Next...